Enhancing Your Vision
Guiding you toward the procedure that fits your unique needs, so you can see the world clearly and confidently.

You’ve been told to wait for the ‘perfect’ 2026 cataract lens. But what if waiting means worse vision or fewer options?
In my Manhattan and New York City practice, I speak with many patients who ask exactly that question
If you’re considering cataract surgery or lens replacement and want to know what’s coming in 2026, this guide is for you. I’ll explain what these new lenses are, who they’re best for, and whether it makes sense to wait—or to move forward now.
I’m Dr. Ilan Cohen, a board‑certified cataract and premium lens surgeon with 25 years of experience and tens of thousands of procedures. You can read more about me here. I have no financial interest in the companies mentioned, and this article is not sponsored. My goal is simple: give you a realistic, practical view so you can make a confident decision.
A cataract is clouding of your eye’s natural lens. During cataract surgery, we replace that cloudy lens with an intraocular lens (IOL) that stays in place permanently. Unlike your youthful natural lens, an IOL doesn’t flex to focus—so the optics you choose define the way you see.
For a quick refresher on cataract timing and symptoms, see my guide: When Is the Right Time for Cataract Surgery?

Below are the lenses patients ask me about most. I’ll keep this practical: what they are, why I use/like them, and the trade‑offs.
I’ve used Vivity for ~5 years with excellent results—especially in pilots, truck drivers, and athletes. It uses wavefront‑shaping to extend focus without rings. Think strong distance and intermediate, and a halo/glare profile close to monofocal. For tiny print, you may still want light readers. Also a thoughtful choice for some patients with mild macular degeneration or glaucoma. Learn about extended‑range options here.
This is the next‑gen PanOptix on the Clareon platform. Early lab and clinical experience suggest improved optical efficiency and less light scatter than prior PanOptix. I started using Pro this year; results have been excellent, and in my hands the halo/glare profile is lower than many other diffractive designs (more on halos below). To understand how trifocals work, visit Multifocal Lens Implants.
I’ve used Odyssey for the last two years. It delivers a full range and particularly shines for distance. That said, in my experience, halos/flare can be higher than with a few other options, and typically subside with time. If you’re curious, I share patient comparisons in my blog posts (browse our Cataract articles).
Distribution began in 2025. There was a limited recall of certain lots that year; unaffected lots are back on the market. My patients’ results have been excellent—distance, intermediate, and near—with a very low incidence of symptomatic halos in my practice when selection and centration are spot‑on. For a big‑picture view of what’s new, see The Latest Advances in Cataract Surgery.
Planned U.S. launch in 2026. LuxSmart extends focus without rings using refractive (smooth) optics. Early data and experience outside the U.S. point to excellent distance/intermediate and monofocal‑like contrast. Near is typically functional (not trifocal‑strong). For heavy computer/tablet users, it looks very compelling. Learn about EDOF design trade‑offs here.
Available in Europe; U.S. approval pending. The promise here is trifocal‑like range without rings. Early reports suggest high independence from glasses with fewer halos, but this is a new platform—we’re all watching for larger, longer‑term data. (I’ll update my observations on the blog as experience grows.)
An established EDOF option outside the U.S. It targets a wide, continuous range into the near‑intermediate zone, with a design meant to reduce scatter compared to some older diffractive lenses. If you’re okay with some halo risk and want more near than typical non‑diffractive EDOF, LARA can be a thoughtful middle ground. See how EDOF compares to multifocals here.
FDA‑approved on Sept 10, 2025; U.S. availability expected in 2026. Early data look very promising, with >95% of patients in trials reporting full spectacle independence across distances and high satisfaction. I’ll share real‑world outcomes once it’s in my hands; keep an eye on our blog.
Broadly used outside the U.S.; anticipated here in early 2026. The design smoothly changes focus power across the lens surface without diffractive steps/rings—aiming for monofocal‑like night comfort with strong intermediate. If you want low halos plus arm’s‑length clarity, PureSee is one to watch.
One of the most exciting new designs: a non‑diffractive spiral optic (AI‑assisted design) that aims to deliver trifocal‑like range without rings and with minimal light scatter. Early clinical experience suggests fewer halos than classic diffractive multifocals. U.S. approval is pending; if early results stay consistent, Galaxy could be a standout for patients who want “no readers” with far fewer night artifacts. I’ll report back on my real‑world cases once available.

Great outcomes don’t depend on the lens alone. Three realities:
I’ll keep tracking real‑world data—especially night‑driving symptoms, stability, and spectacle independence—and I’ll update you as these ring‑less concepts prove themselves beyond early trials. For more context on current tools and techniques, see The Latest Advances in Cataract Surgery and Game‑Changing Cataract Lenses for 2025.
If you’re debating laser‑assisted cataract surgery vs. a traditional blade approach, start here: Laser‑Assisted Cataract Surgery. It walks through how the laser improves precision, astigmatism management, and lens placement.
Whether you want the lowest halos or the most reading freedom, we’ll map your goals to a lens—and a surgical plan—that fits your eyes. When you’re ready, schedule a consultation and we’ll decide together whether to act now or plan around the 2026 arrivals.
Guiding you toward the procedure that fits your unique needs, so you can see the world clearly and confidently.




If you do not see your preferred date and time please call the office, so we can accommodate your request (917) 398-4011.